BiotechTube
Home/Abon Pharmaceuticals/Salah Ahmed, Ph.D.
SA

Salah Ahmed, Ph.D.

Chief Scientific Officer, President & CEO

Abon Pharmaceuticals

Therapeutic Areas

GastrointestinalBroad Portfolio

Abon Pharmaceuticals Pipeline

DrugIndicationPhase
Generic Sucralfate Oral SuspensionDuodenal Ulcers (Generic of Carafate®)Approved